Assessment of ocular surface toxicity after topical instillation of nitric oxide donors

Arquivos Brasileiros de Oftalmologia

Volumn 76, Issue 1, 2013, Pages 38-41

  Cariello, Angelino Julio ^a   de Souza, Gabriela Freitas Pereira ^b   Lowen, Márcia Serva ^a   de Oliveira, Marcelo Ganzarolli ^b   Höfling Lima, Ana Luisa ^a  

^a FEDERAL UNIVERSITY OF SÃO PAULO   (Brazil)

^b UNIVERSITY OF CAMPINAS   (Brazil)

Author keywords

Drug toxicity; Methylcellulose; Nitric oxide donors; S nitrosoglutathione; S nitrosothiols

Indexed keywords

ACETYLCYSTEINE; DRUG DERIVATIVE; N ACETYL S NITROSOCYSTEINE; NITRIC OXIDE DONOR; S NITROSOGLUTATHIONE; S-NITROSO-N-ACETYLCYSTEINE;

ANIMAL; ARTICLE; DOSE RESPONSE; DRUG EFFECT; DRUG INSTILLATION; EYE; MALE; PATHOLOGY; RABBIT; RANDOMIZATION; SWINE;

ACETYLCYSTEINE; ANIMALS; DOSE-RESPONSE RELATIONSHIP, DRUG; EYE; INSTILLATION, DRUG; MALE; NITRIC OXIDE DONORS; RABBITS; RANDOM ALLOCATION; S-NITROSOGLUTATHIONE; SWINE;

EID: 84880407554     PISSN: 00042749     EISSN: 16782925     Source Type: Journal    
DOI: 10.1590/S0004-27492013000100011     Document Type: Article

References (38)

1. Wanstall JC, Jeffery TK, Gambino A, Lovren F, Triggle CR. Vascular smooth muscle relaxation mediated by nitric oxide donors: a comparison with acetylcholine, nitric oxide and nitroxyl ion. Br J Pharmacol. 2001;134(3):463-72.
2. Bogdan C. Nitric oxide and the immune response. Nat Immunol. 2001;2(10):907-16. Review.
3. Gladwin MT, Shelhamer JH, Schechter AN, Pease-Fye ME, Waclawiw MA, Panza JA, et al. Role of circulating nitrite and S-nitrosohemoglobin in the regulation of regional blood flow in humans. Proc Natl Acad Sci U S A. 2000;97(21):11482-7.
4. MacArthur PH, Shiva S, Gladwin MT. Measurement of circulating nitrite and S-nitrosothiols by reductive chemiluminescence. J Chromatogr B Analyt Technol Biomed Life Sci. 2007;851(1-2):93-105.
5. Ricardo KF, Shishido SM, de Oliveira MG, Krieger MH. Characterization of the hypotensive effect of S-nitroso-N-acetylcysteine in normotensive and hypertensive conscious rats. Nitric Oxide. 2002;7(1):57-66.
6. Seabra AB, Pankotai E, Fehér M, Somlai A, Kiss L, Bíró L, et al. S-nitrosoglutathionecontaining hydrogel increases dermal blood flow in streptozotocin-induced diabetic rats. Br J Dermatol. 2007;156(5):814-8.
7. Yao K, Tschudi M, Flammer J, Lüscher TF. Endothelium-dependent regulation of vascular tone of the porcine ophthalmic artery. Invest Ophthalmol Vis Sci. 1991; 32(6):1791-8.
8. Lockhart CJ, Gamble AJ, Rea D, Hughes S, McGivern RC, Wolsley C, et al. Nitric oxide modulation of ophthalmic artery blood flow velocity waveform morphology in healthy volunteers. Clin Sci (Lond). 2006;111(1):47-52.
9. Luksch A, Polak K, Beier C, Polska E, Wolzt M, Dorner GT, et al. Effects of systemic NO synthase inhibition on choroidal and optic nerve head blood flow in healthy subjects. Invest Ophthalmol Vis Sci. 2000;41(10):3080-4.
10. Dorner GT, Garhofer G, Kiss B, Polska E, Polak K, Riva CE, et al. Nitric oxide regulates retinal vascular tone in humans. Am J Physiol Heart Circ Physiol. 2003;285(2):H631-6.
11. Simader C, Lung S, Weigert G, Kolodjaschna J, Fuchsjäger-Mayrl G, Schmetterer L, et al. Role of NO in the control of choroidal blood flow during a decrease in ocular perfusion pressure. Invest Ophthalmol Vis Sci. 2009;50(1):372-7.
12. Grunwald JE, Iannaccone A, DuPont J. Effect of isosorbide mononitrate on the human optic nerve and choroidal circulations. Br J Ophthalmol. 1999;83(2):162-7.
13. Schmetterer L, Polak K. Role of nitric oxide in the control of ocular blood flow. Prog Retin Eye Res. 2001;20(6):823-47.
14. Behar-Cohen FF, Goureau O, D'Hermies F, Courtois Y. Decreased intraocular pressure induced by nitric oxide donors is correlated to nitrite production in the rabbit eye. Invest Ophthalmol Vis Sci. 1996;37(8):1711-5.
15. Carreiro S, Anderson S, Gukasyan HJ, Krauss A, Prasanna G. Correlation of in vitro and in vivo kinetics of nitric oxide donors in ocular tissues. J Ocul Pharmacol Ther. 2009; 25(2):105-12.
16. Chuman H, Chuman T, Nao-i N, Sawada A. The effect of L-arginine on intraocular pressure in the human eye. Curr Eye Res. 2000;20(6):511-6.
17. Kotikoski H, Alajuuma P, Moilanen E, Salmenperä P, Oksala O, Laippala P, et al. Comparison of nitric oxide donors in lowering intraocular pressure in rabbits: role of cyclic GMP. J Ocul Pharmacol Ther. 2002;18(1):11-23. Erratum in J Ocul Pharmacol Ther. 2002;18(4):389.
18. Kaplan SS, Lancaster JR Jr, Basford RE, Simmons RL. Effect of nitric oxide on staphylococcal killing and interactive effect with superoxide. Infect Immun. 1996;64(1):69-76.
19. Stroeher UH, Kidd SP, Stafford SL, Jennings MP, Paton JC, McEwan AG. A pneumococcal MerR-like regulator and S-nitrosoglutathione reductase are required for systemic virulence. J Infect Dis. 2007;196(12):1820-6.
20. Cariello AJ, Bispo PJ, de Souza GF, Pignatari AC, de Oliveira MG, Hofling-Lima AL. Bactericidal effect of S-nitrosothiols against clinical isolates from keratitis. Clin Ophthalmol. 2012;6:1907-14.
21. Cariello AJ, de Souza GF, Foronda AS, Yu MC, Höfling-Lima AL, de Oliveira MG. In vitro amoebicidal activity of S-nitrosoglutathione and S-nitroso-N-acetylcysteine against trophozoites of Acanthamoeba castellanii. J Antimicrob Chemother. 2010;65(3):588-91.
22. Bonfiglio V, Camillieri G, Avitabile T, Leggio GM, Drago F. Effects of the COOH-terminal tripeptide alpha-MSH(11-13) on corneal epithelial wound healing: role of nitric oxide. Exp Eye Res. 2006;83(6):1366-72.
23. Tannous M, Hutnik CM, Tingey DP, Mutus B. S-nitrosoglutathione photolysis as a novel therapy for antifibrosis in filtration surgery. Invest Ophthalmol Vis Sci. 2000;41(3): 749-55.
24. Haq E, Rohrer B, Nath N, Crosson CE, Singh I. S-nitrosoglutathione prevents interphotoreceptor retinoid-binding protein (IRBP(161-180))-induced experimental autoimmune uveitis. J Ocul Pharmacol Ther. 2007;23(3):221-31.
25. de Souza GF, Yokoyama-Yasunaka JK, Seabra AB, Miguel DC, de Oliveira MG, Uliana SR. Leishmanicidal activity of primary S-nitrosothiols against Leishmania major and Leishmania amazonensis: implications for the treatment of cutaneous leishmaniasis. Nitric Oxide. 2006;15(3):209-16.
26. Chambers WA, Green S, Gupta KC, Hill RN, Huntley K, Hurley PM, et al. Scoring for eye irritation tests. Food Chem Toxicol. 1993;31(2):111-5.
27. Wilhelmus KR. The Draize eye test. Surv Ophthalmol. 2001;45(6):493-515.
28. Liang H, Baudouin C, Faure MO, Lambert G, Brignole-Baudouin F. Comparison of the ocular tolerability of a latanoprost cationic emulsion versus conventional formulations of prostaglandins: an in vivo toxicity assay. Mol Vis. 2009;15:1690-9.
29. Liang H, Baudouin C, Pauly A, Brignole-Baudouin F. Conjunctival and corneal reactions in rabbits following short-and repeated exposure to preservative-free tafluprost, commercially available latanoprost and 0.02% benzalkonium chloride. Br J Ophthalmol. 2008;92(9):1275-82.
30. McNamee P, Hibatallah J, Costabel-Farkas M, Goebel C, Araki D, Dufour E, et al. A tiered approach to the use of alternatives to animal testing for the safety assessment of cosmetics: eye irritation. Regul Toxicol Pharmacol. 2009;54(2):197-209.
31. Vinardell MP, Mitjans M. Alternative methods for eye and skin irritation tests: an overview. J Pharm Sci. 2008;97(1):46-59.
32. Piehl M, Gilotti A, Donovan A, DeGeorge G, Cerven D. Novel cultured porcine corneal irritancy assay with reversibility endpoint. Toxicol In Vitro. 2010;24(1):231-9.
33. Burstein NL, Anderson JA. Corneal penetration and ocular bioavailability of drugs. J Ocul Pharmacol. 1985;1(3):309-26.
34. Waseem M, Rustam N, Qamar ul Islam. Intraocular pressure after phacoemulsification using hydroxypropyl methylcellulose and sodium hyaluronate as viscoelastics. J Ayub Med Coll Abbottabad. 2007;19(1):42-5.
35. Lozano JS, Chay EY, Healey J, Sullenberger R, Klarlund JK. Activation of the epidermal growth factor receptor by hydrogels in artificial tears. Exp Eye Res. 2008;86(3):500-5.
36. Srividya B, Cardoza RM, Amin PD. Sustained ophthalmic delivery of ofloxacin from a pH triggered in situ gelling system. J Control Release. 2001;73(2-3):205-11.
37. Liu Z, Li J, Nie S, Liu H, Ding P, Pan W. Study of an alginate/HPMC-based in situ gelling ophthalmic delivery system for gatifloxacin. Int J Pharm. 2006;315(1-2):12-7.
38. Al-Kassas RS, El-Khatib MM. Ophthalmic controlled release in situ gelling systems for ciprofloxacin based on polymeric carriers. Drug Deliv. 2009;16(3):145-52.